Innovation
10 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 586 times.
| Year | Filings |
|---|---|
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 4 |
Social engagement
Social engagement: 1.9K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
Recent activity
8 Jun 2026
Product launch
SOF-SKNTM manufacturing for a clinical trial
1 Jun 2026
Event
Therapies for Autoimmune Diseases
25 May 2026
Product launch
Toll-like receptor 8 (TLR8)